Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist

Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist

US Patent 10023560 · Granted Jul 17, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyridin-3-yl derivatives2025
Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their 2025
Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their 2025
Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan2025
Crystalline forms2025
N-substituted indole derivatives as PGE2 receptor modulators2024
Pyrimidine derivatives as PGE2 receptor modulators2023
Pyrimidine derivatives as PGE2 receptor modulators2023
Phenyl derivatives as PGE2 receptor modulators2023
Phenyl derivatives as PGE2 receptor modulators2023
Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan2023
Crystalline form of N-[1-(5-cyano-pyridin-2-ylmethyl)-1 H-pyrazol-3-yl]-2- [4-(12023